You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 49 No. 1, January 1992 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Retinocalcarine Function in Alzheimer's Disease

A Clinical and Electrophysiological Study

Joseph F. Rizzo III, MD; Alice Cronin-Golomb, PhD; John H. Growdon, MD; Suzanne Corkin, PhD; T. John Rosen, PhD; Michael A. Sandberg, PhD; Keith H. Chiappa, MD; Simmons Lessell, MD

Arch Neurol. 1992;49(1):93-101.


Abstract



• Impaired visual function in Alzheimer's disease (AD) could result from either precortical or cortical lesions, or both. In a parallel psychophysical study of visual function in AD, we found that contrast sensitivity function, color vision, stereoacuity, and back-ward masking were impaired relative to the performance of age-matched control subjects, whereas performance on a critical flicker fusion test was normal. The intent of the present study was to determine whether abnormalities of the retinocalcarine pathway contribute to visual dysfunction. We performed neuro-ophthalmological examinations on 38 patients with AD; from this group, 25 received additional psychophysical testing and 13 underwent electrophysiological testing. Clinical neuro-ophthalmological examinations, full-field electroretinograms, focal electroretinograms, and pattern visual evoked potentials were normal in all patients tested. There was no evidence of retinocalcarine abnormality specific to AD. We conclude that the visual impairment experienced by some patients with AD primarily results from involvement of the visual association cortices rather than from precortical damage, at least before the end stage of the disease.



Author Affiliations



From the Department of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary (Drs Rizzo, Sandberg, and Lessell), the Department of Psychology, Boston University (Dr Cronin-Golomb), the Department of Neurology, Massachusetts General Hospital (Drs Growdon and Chiappa), and the Department of Neurology, Boston University School of Medicine (Dr Rosen), Boston; and the Department of Brain and Cognitive Sciences and the Clinical Research Center, Massachusetts Institute of Technology, Cambridge (Dr Corkin).


Footnotes



Accepted for publication July 11, 1991.

Reprint requests to Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114 (Dr Rizzo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinal Abnormalities in Early Alzheimer's Disease
Berisha et al.
IOVS 2007;48:2285-2289.
ABSTRACT | FULL TEXT  

A Screening Test for Integrative Visual Dysfunction in Alzheimer's Disease
Trobe and Butter
Arch Ophthalmol 1993;111:815-818.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.